A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

Scientists have made a groundbreaking discovery linking Covid to cancer regression, potentially opening new avenues for ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

A clinical trial of 52 people with long Covid who were prescribed low doses of lithium aspartate revealed that it failed to ...

The number of trials has more than doubled in the last several years; court staff attribute the increase primarily to growth.

While countless long COVID sufferers put Pretorius’s theory to the test, her new focus is raising its awareness. Not only ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight ...

It's almost eight years since The Athletic's Jacob Tanswell left Bournemouth — he chats with former team-mates to discuss ...